Monocacy Therapeutics
PrivateLast Round
Seed Round
Aug 28, 2026
Total Funding Raised
$5,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Monocacy Therapeutics is a biotechnology company developing first-in-class immune medicines guided by artificial intelligence to restore optimal immune function and health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monocacy Therapeutics Comparables
Compare Monocacy Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Earendil Labs | 87% | |
| Engimmune Therapeutics | 79% | |
| Infinitopes Precision Immunomics | 77% |
Monocacy Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 28, 2026 | ||||
| Seed Round | Aug 28, 2026 | ||||
| Grant | Jul 2, 2026 | ||||
| Seed Round | May 27, 2026 |
Monocacy Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
$150K raised in Seed Round.
- Aug 28, 2026
$125K raised in Seed Round.
Monocacy Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Monocacy Therapeutics's valuation, stock price, and market status.
Is Monocacy Therapeutics a public or private company?
Monocacy Therapeutics is a private company.
What is the current stock price of Monocacy Therapeutics?
Monocacy Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Monocacy Therapeutics worth (valuation)?
Valuation information for Monocacy Therapeutics is not publicly available.
Can I buy Monocacy Therapeutics stock?
Monocacy Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Monocacy Therapeutics's last funding round?
Monocacy Therapeutics's most recent funding round was Grant on July 2, 2026.
Who are the main investors in Monocacy Therapeutics?
Key investors in Monocacy Therapeutics include TEDCO.
Will Monocacy Therapeutics IPO soon?
No public IPO plans have been announced for Monocacy Therapeutics.
How can I track Monocacy Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Monocacy Therapeutics's secondary market activity and sign up for updates.